Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Finding savings in your budget can free up more funds. Learn where to look for potential savings and enhance your budget.
18,279 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
As AI and data demand surge, investors eye NuScale Power and the small modular reactor trend. Can nuscale power next ...
Cava's yearly revenue just crossed the $1 billion mark, signaling a major milestone for the fast-casual chain. This a...
A clear, investor-friendly look at arcosa (aca) 2025 earnings through the lens of the Q4 2025 earnings call. Learn wh...
Circle stock jumped february as investors weighed an earnings beat against a choppy crypto backdrop. This article unp...
Rocket Lab’s stock faced a sharp pullback before rebounding in March. This article breaks down what caused the drop, ...
Is Bloom Energy a buy, sell, or hold in 2026? This guide breaks down the business, potential catalysts, and key risks...
When a leading shipping stock leaps by a double-digit percentage, traders watch closely for what's driving the gains....
A bold investment in a brain health biotech signals conviction in early-stage science. This article breaks down what ...
Amazon is pursuing a colossal 2026 investment plan centered on AI and cloud tech. This guide breaks down the risks, p...
Investors are weighing a shift from high-growth tech to more income-driven energy plays as AI-era capex creates uncer...
The National Taxpayer Advocate says tens millions taxpayers owed refunds or relief may be available due to COVID-era ...